NCT06264687View on ClinicalTrials.gov

Hepcidin After Intravenous Iron Treatment

Not yet recruitingOBSERVATIONAL

Enrollment

10

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions

Iron Deficiency (Without Anemia)

All Listed Sponsors

lead

Pierre-Alexandre Krayenbühl

OTHER

NCT06264687 - Hepcidin After Intravenous Iron Treatment | Biotech Hunter | Biotech Hunter